Created at	Source	Raw Value	Validated value
Jan. 21, 2022, 2 a.m.	oms	Immunogenicity: neutralising antibody titres against S1/S2 and RBD measured by electrochemiluminescence at baseline; 28 days and 45 days after complete vaccination	Immunogenicity: neutralising antibody titres against S1/S2 and RBD measured by electrochemiluminescence at baseline; 28 days and 45 days after complete vaccination